We are analyzing https://link.springer.com/article/10.1007/s13277-012-0543-8.

Title:
Effect of TRAF6 on the biological behavior of human lung adenocarcinoma cell | Tumor Biology
Description:
Tumor necrosis factor receptor-associated factor 6 (TRAF6) is a unique adaptor protein of the tumor necrosis factor receptor-associated factor family that mediates both tumor necrosis factor receptor and interleukin-1 receptor/Toll-like receptor signaling. A recent study showed that TRAF6 played an important role in tumorigenesis and invasion through activation of nuclear factor kappa B (NF-κB). However, the biological role of TRAF6 remains unknown in lung cancer up to now. To address the expression of TRAF6 in lung cancer cells, four lung cancer cell lines (A549, HCC827, NCI-H292, and 95-D) and human bronchial epithelial cells were used to detect the expression of TRAF6 protein by western blotting. Results indicated that TRAF6 displayed an upregulation in human lung cancer cell lines. To investigate the effects of TRAF6 on the biological behavior of human lung adenocarcinoma cell, we generated human lung adenocarcinoma A549 cell line in which TRAF6 was depleted. The results showed that downregulation of TRAF6 could decrease cell viability, suppress cell proliferation and invasion, and promote cell apoptosis. At the same time, we explored the effects of TRAF6 on the expression of the following proteins: phosphor-NF-κB (p-p65), cyclin D1, caspase-3, and matrix metalloproteinase 9 (MMP9). Downregulation of TRAF6 could decrease the expression of p-p65, cyclin D1, and MMP9 and increase the expression of caspase-3. All these results suggested that TRAF6 might be involved in the potentiation of growth, proliferation, and invasion of A549 cell line, as well as the inhibition of A549 cell apoptosis by the activation of NF-κB. To make a long story short, the overexpression of TRAF6 might be related to the tumorigenesis and invasion of lung cancer.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Telecommunications
Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We're unsure if the website is profiting.

Websites don't always need to be profitable; some serve as platforms for education or personal expression. Websites can serve multiple purposes. And this might be one of them. Link.springer.com might be making money, but it's not detectable how they're doing it.

Keywords {🔍}

article, google, scholar, pubmed, cas, traf, cell, cancer, factor, lung, activation, tumor, signaling, invasion, biol, necrosis, nfkappab, protein, nuclear, human, receptor, cells, wang, chem, proliferation, receptorassociated, expression, apoptosis, kinase, res, mol, factorkappab, chen, family, access, zhang, privacy, cookies, content, growth, carcinoma, pathway, inhibits, gene, products, sun, publish, research, search, biological,

Topics {✒️}

uv-induced nf-kappab activation transcription factor nf-kappab nf-kappab-inducing kinase nf-kappab/cyclin d1 pathway month download article/chapter glycogen synthase kinase-3beta suppressing nuclear factor-kappab traf-6/tak-1 protein complex lung cancer biomarkers cytokine-induced mmp-9 synthesis nuclear factor-kappab signaling nuclear factor-kappab activation early-stage lung adenocarcinomas ret/ptc fusion oncoprotein tumor necrosis factor promote cell apoptosis nf-kappab pathways paracrine tnfalpha signalling nf-kappab activation squamous cell carcinoma nuclear factor-kappab nuclear factor kappab ring-dependent traf6 polyubiquitination nf-kappab activator ikappabalpha kinase activation transforming activities emanating a549 cell line growth factor receptor-1 human lung cancer full article pdf factor family protein ubiquitin-specific protease 4 alpha kinase interleukin-1 receptor/toll traf2-mediated activation nuclear factor kappa unique adaptor protein lung cancer risk putative signal transducers lung cancer cells privacy choices/manage cookies apoptotic genes induced human colorectal cancer a549 cell apoptosis cancer cell survival human breast cancer factor protein inhibits cellular invasion /interleukin-1 receptor signaling phosphor-nf-κb

Questions {❓}

Lung cancer and lung stem cells: strange bedfellows?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Effect of TRAF6 on the biological behavior of human lung adenocarcinoma cell
         description:Tumor necrosis factor receptor-associated factor 6 (TRAF6) is a unique adaptor protein of the tumor necrosis factor receptor-associated factor family that mediates both tumor necrosis factor receptor and interleukin-1 receptor/Toll-like receptor signaling. A recent study showed that TRAF6 played an important role in tumorigenesis and invasion through activation of nuclear factor kappa B (NF-κB). However, the biological role of TRAF6 remains unknown in lung cancer up to now. To address the expression of TRAF6 in lung cancer cells, four lung cancer cell lines (A549, HCC827, NCI-H292, and 95-D) and human bronchial epithelial cells were used to detect the expression of TRAF6 protein by western blotting. Results indicated that TRAF6 displayed an upregulation in human lung cancer cell lines. To investigate the effects of TRAF6 on the biological behavior of human lung adenocarcinoma cell, we generated human lung adenocarcinoma A549 cell line in which TRAF6 was depleted. The results showed that downregulation of TRAF6 could decrease cell viability, suppress cell proliferation and invasion, and promote cell apoptosis. At the same time, we explored the effects of TRAF6 on the expression of the following proteins: phosphor-NF-κB (p-p65), cyclin D1, caspase-3, and matrix metalloproteinase 9 (MMP9). Downregulation of TRAF6 could decrease the expression of p-p65, cyclin D1, and MMP9 and increase the expression of caspase-3. All these results suggested that TRAF6 might be involved in the potentiation of growth, proliferation, and invasion of A549 cell line, as well as the inhibition of A549 cell apoptosis by the activation of NF-κB. To make a long story short, the overexpression of TRAF6 might be related to the tumorigenesis and invasion of lung cancer.
         datePublished:2012-10-04T00:00:00Z
         dateModified:2012-10-04T00:00:00Z
         pageStart:231
         pageEnd:239
         sameAs:https://doi.org/10.1007/s13277-012-0543-8
         keywords:
            TRAF6
            Lung cancer
            Proliferation
            Apoptosis
            Invasion
            Cancer Research
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-012-0543-8/MediaObjects/13277_2012_543_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-012-0543-8/MediaObjects/13277_2012_543_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-012-0543-8/MediaObjects/13277_2012_543_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-012-0543-8/MediaObjects/13277_2012_543_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-012-0543-8/MediaObjects/13277_2012_543_Fig5_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-012-0543-8/MediaObjects/13277_2012_543_Fig6_HTML.gif
         isPartOf:
            name:Tumor Biology
            issn:
               1423-0380
               1010-4283
            volumeNumber:34
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Netherlands
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Lou Zhong
               affiliation:
                     name:Affiliated Hospital of Nantong University
                     address:
                        name:Department of Thoracic Surgery, Affiliated Hospital of Nantong University, Nantong, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Fei Cao
               affiliation:
                     name:Affiliated Hospital of Nantong University
                     address:
                        name:Department of Thoracic Surgery, Affiliated Hospital of Nantong University, Nantong, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Qingsheng You
               affiliation:
                     name:Affiliated Hospital of Nantong University
                     address:
                        name:Department of Thoracic Surgery, Affiliated Hospital of Nantong University, Nantong, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Effect of TRAF6 on the biological behavior of human lung adenocarcinoma cell
      description:Tumor necrosis factor receptor-associated factor 6 (TRAF6) is a unique adaptor protein of the tumor necrosis factor receptor-associated factor family that mediates both tumor necrosis factor receptor and interleukin-1 receptor/Toll-like receptor signaling. A recent study showed that TRAF6 played an important role in tumorigenesis and invasion through activation of nuclear factor kappa B (NF-κB). However, the biological role of TRAF6 remains unknown in lung cancer up to now. To address the expression of TRAF6 in lung cancer cells, four lung cancer cell lines (A549, HCC827, NCI-H292, and 95-D) and human bronchial epithelial cells were used to detect the expression of TRAF6 protein by western blotting. Results indicated that TRAF6 displayed an upregulation in human lung cancer cell lines. To investigate the effects of TRAF6 on the biological behavior of human lung adenocarcinoma cell, we generated human lung adenocarcinoma A549 cell line in which TRAF6 was depleted. The results showed that downregulation of TRAF6 could decrease cell viability, suppress cell proliferation and invasion, and promote cell apoptosis. At the same time, we explored the effects of TRAF6 on the expression of the following proteins: phosphor-NF-κB (p-p65), cyclin D1, caspase-3, and matrix metalloproteinase 9 (MMP9). Downregulation of TRAF6 could decrease the expression of p-p65, cyclin D1, and MMP9 and increase the expression of caspase-3. All these results suggested that TRAF6 might be involved in the potentiation of growth, proliferation, and invasion of A549 cell line, as well as the inhibition of A549 cell apoptosis by the activation of NF-κB. To make a long story short, the overexpression of TRAF6 might be related to the tumorigenesis and invasion of lung cancer.
      datePublished:2012-10-04T00:00:00Z
      dateModified:2012-10-04T00:00:00Z
      pageStart:231
      pageEnd:239
      sameAs:https://doi.org/10.1007/s13277-012-0543-8
      keywords:
         TRAF6
         Lung cancer
         Proliferation
         Apoptosis
         Invasion
         Cancer Research
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-012-0543-8/MediaObjects/13277_2012_543_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-012-0543-8/MediaObjects/13277_2012_543_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-012-0543-8/MediaObjects/13277_2012_543_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-012-0543-8/MediaObjects/13277_2012_543_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-012-0543-8/MediaObjects/13277_2012_543_Fig5_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-012-0543-8/MediaObjects/13277_2012_543_Fig6_HTML.gif
      isPartOf:
         name:Tumor Biology
         issn:
            1423-0380
            1010-4283
         volumeNumber:34
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Netherlands
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Lou Zhong
            affiliation:
                  name:Affiliated Hospital of Nantong University
                  address:
                     name:Department of Thoracic Surgery, Affiliated Hospital of Nantong University, Nantong, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Fei Cao
            affiliation:
                  name:Affiliated Hospital of Nantong University
                  address:
                     name:Department of Thoracic Surgery, Affiliated Hospital of Nantong University, Nantong, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Qingsheng You
            affiliation:
                  name:Affiliated Hospital of Nantong University
                  address:
                     name:Department of Thoracic Surgery, Affiliated Hospital of Nantong University, Nantong, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Tumor Biology
      issn:
         1423-0380
         1010-4283
      volumeNumber:34
Organization:
      name:Springer Netherlands
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Affiliated Hospital of Nantong University
      address:
         name:Department of Thoracic Surgery, Affiliated Hospital of Nantong University, Nantong, People’s Republic of China
         type:PostalAddress
      name:Affiliated Hospital of Nantong University
      address:
         name:Department of Thoracic Surgery, Affiliated Hospital of Nantong University, Nantong, People’s Republic of China
         type:PostalAddress
      name:Affiliated Hospital of Nantong University
      address:
         name:Department of Thoracic Surgery, Affiliated Hospital of Nantong University, Nantong, People’s Republic of China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Lou Zhong
      affiliation:
            name:Affiliated Hospital of Nantong University
            address:
               name:Department of Thoracic Surgery, Affiliated Hospital of Nantong University, Nantong, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Fei Cao
      affiliation:
            name:Affiliated Hospital of Nantong University
            address:
               name:Department of Thoracic Surgery, Affiliated Hospital of Nantong University, Nantong, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Qingsheng You
      affiliation:
            name:Affiliated Hospital of Nantong University
            address:
               name:Department of Thoracic Surgery, Affiliated Hospital of Nantong University, Nantong, People’s Republic of China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Thoracic Surgery, Affiliated Hospital of Nantong University, Nantong, People’s Republic of China
      name:Department of Thoracic Surgery, Affiliated Hospital of Nantong University, Nantong, People’s Republic of China
      name:Department of Thoracic Surgery, Affiliated Hospital of Nantong University, Nantong, People’s Republic of China
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(175)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Particles.js
Prism.js

CDN Services {📦}

Crossref

4.12s.

LINK . SPRINGER . COM {}